Clinical data on patients
Patient no./sex . | Source . | Type . | Cytogenetic abnormality . | FAB category . | Blast % . | Blasts in BM, % . | WBC count, × 109/L . |
|---|---|---|---|---|---|---|---|
| 1/M | BM | AML | Miscellaneous | M2 | 75 | 90 | 26.7 |
| 2/M | BM | Leukemia | t(8;21) | M2 | 90 | 95 | 60.0 |
| 3/M | BM | AML | +21 | M2 | 74 | 85 | 32.0 |
| 4/F | PB | AML | Miscellaneous | M4 | 92 | 95 | 24.7 |
| 5/M | BM | Leukemia | Diploid | M5b | 82 | 80 | 68.9 |
| 6/M | BM | AML | t(9;22) | Blast crisis | 82 | 95 | 47.7 |
| 7/F | BM | AML | Miscellaneous | M5b | 85 | 45 | 106.1 |
| 8/M | BM | AML | Miscellaneous | M4 | 85 | 95 | 60.5 |
| 9/F | BM | AML | Miscellaneous | M4 | 90 | 90 | 116.7 |
| 10/M | BM | AML | Pseudodiploid | M0 | 71 | 45 | 32.6 |
Patient no./sex . | Source . | Type . | Cytogenetic abnormality . | FAB category . | Blast % . | Blasts in BM, % . | WBC count, × 109/L . |
|---|---|---|---|---|---|---|---|
| 1/M | BM | AML | Miscellaneous | M2 | 75 | 90 | 26.7 |
| 2/M | BM | Leukemia | t(8;21) | M2 | 90 | 95 | 60.0 |
| 3/M | BM | AML | +21 | M2 | 74 | 85 | 32.0 |
| 4/F | PB | AML | Miscellaneous | M4 | 92 | 95 | 24.7 |
| 5/M | BM | Leukemia | Diploid | M5b | 82 | 80 | 68.9 |
| 6/M | BM | AML | t(9;22) | Blast crisis | 82 | 95 | 47.7 |
| 7/F | BM | AML | Miscellaneous | M5b | 85 | 45 | 106.1 |
| 8/M | BM | AML | Miscellaneous | M4 | 85 | 95 | 60.5 |
| 9/F | BM | AML | Miscellaneous | M4 | 90 | 90 | 116.7 |
| 10/M | BM | AML | Pseudodiploid | M0 | 71 | 45 | 32.6 |
FAB indicates French-American-British; BM, bone marrow; WBC, white blood cell; M, male; PB, peripheral blood; F, female.